<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Propranolol - Drug Info</title>
  <!-- Font Awesome CDN for icons -->
  <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.5.0/css/all.min.css">
  <style>
    body {
      font-family: Arial, sans-serif;
      margin: 20px;
      background-color: #f4f8fb;
      color: #333;
    }
    h1, h2 {
      color: #003366;
    }
    .section {
      margin-bottom: 20px;
    }
    .section p {
      margin: 5px 0;
    }
    table {
      width: 100%;
      border-collapse: collapse;
      background-color: #ffffff;
    }
    table, th, td {
      border: 1px solid #ccc;
    }
    th, td {
      padding: 12px;
      text-align: left;
    }
    th {
      background-color: #e3f2fd;
      color: #003366;
    }
    .icon {
      color: #007acc;
      margin-right: 8px;
    }
  </style>
</head>
<body>

  <h1>Drug Information: Propranolol</h1>

  <div class="section">
    <h2>Generic Name:</h2>
    <p>Propranolol</p>
  </div>

  <div class="section">
    <h2>Description:</h2>
    <p>Propranolol is a non-selective beta-adrenergic receptor blocker. It reduces heart rate, myocardial contractility, and cardiac output. It also suppresses renin release from the kidneys.</p>
  </div>

  <div class="section">
    <h2>Indication:</h2>
    <p>Used for hypertension, angina pectoris, arrhythmias, myocardial infarction, migraine prophylaxis, essential tremor, and anxiety-related tachycardia.</p>
  </div>

  <div class="section">
    <h2>Off-Label Uses:</h2>
    <p>Management of thyrotoxicosis, portal hypertension, performance anxiety, and aggressive behavior in psychiatric patients.</p>
  </div>

  <div class="section">
    <h2>Kinetic Profiling (ADME):</h2>
    <table>
      <tr>
        <th><i class="fas fa-pills icon"></i>Component</th>
        <th><i class="fas fa-info-circle icon"></i>Details</th>
      </tr>
      <tr>
        <td><i class="fas fa-arrow-down icon"></i>Absorption</td>
        <td>Rapidly absorbed but undergoes significant first-pass metabolism (bioavailability ~25%)</td>
      </tr>
      <tr>
        <td><i class="fas fa-random icon"></i>Distribution</td>
        <td>Widely distributed; crosses the blood-brain barrier</td>
      </tr>
      <tr>
        <td><i class="fas fa-flask icon"></i>Metabolism</td>
        <td>Hepatically metabolized via CYP enzymes</td>
      </tr>
      <tr>
        <td><i class="fas fa-toilet icon"></i>Excretion</td>
        <td>Mainly excreted in urine as metabolites</td>
      </tr>
    </table>
  </div>

  <div class="section">
    <h2>Interactions:</h2>
    <ul>
      <li><strong>Adverse Effects:</strong> Bradycardia, hypotension, fatigue, dizziness, depression, bronchospasm (especially in asthmatics)</li>
      <li><strong>Side Effects:</strong> Nausea, sleep disturbances, cold extremities, sexual dysfunction</li>
    </ul>
  </div>

  <div class="section">
    <h2>Pregnancy Class:</h2>
    <p>FDA Pregnancy Category C: Risk cannot be ruled out. Use only if clearly needed and potential benefits justify potential risks to the fetus.</p>
  </div>

  <div class="section">
    <h2>Commonly Available Brands in Pakistan:</h2>
    <ul>
      <li>Inderal</li>
      <li>Prolol</li>
      <li>Deralin</li>
      <li>Beta-Pro</li>
    </ul>
  </div>

  <div class="section">
    <h2>Recommended Dose:</h2>
    <p>
      Varies based on indication. <br>
      <strong>Hypertension:</strong> 40–80 mg twice daily, up to 320 mg/day. <br>
      <strong>Migraine prophylaxis:</strong> 80–160 mg/day in divided doses. <br>
      <strong>Anxiety:</strong> 10–40 mg before stressful events.
    </p>
  </div>

  <div class="section">
    <h2>Reference:</h2>
    <p>Dipiro’s Pharmacotherapy: A Pathophysiologic Approach, 12th Edition</p>
    <p>British National Formulary (BNF)</p>
    <p>Drug information from Medscape and Drugs.com</p>
  </div>

</body>
</html>
